ACIP votes to expand recommendation for Pfizer’s RSV vaccine ABRYSVO to include adults aged 50 – 59 at increased risk of disease
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
Strengthening capabilities in Peptide Therapeutics and CDMO services
Experts urge early detection & better access to care
403 entries from 22 states covering 168 districts highlight groundbreaking initiatives vital to improving national nutrition metrics.
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K.
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Offers affordable, high-quality solutions for diabetes care
Lonza to develop spray-dried formulations for an intranasally-delivered biologic for Iconovo at its Center of Excellence for bioavailability enhancement and inhaled delivery in Bend (US)
Subscribe To Our Newsletter & Stay Updated